COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,699 Articles (22,913 medRxiv, 8,786 bioRxiv)

Most recent first Previous |  Page 1924: Articles 19231-19240  | Next

Deficient hand washing facilities in public toilets in the time of the COVID-19 pandemic: A survey in one high-income country
Wilson, N., Thomson, G.
10.1101/2021.01.19.21250124 — Posted: 2021-01-20
Sleep in Frontline Healthcare Workers on Social Media During the COVID-19 Pandemic
Stewart, N. H., Koza, A. L., Dhaon, S., Shoushtari, C., Martinez, M., Arora, V. M.
10.1101/2021.01.19.21250128 — Posted: 2021-01-20
Exploring overcrowding trends in an inner city emergence department in the UK before and during COVID-19 epidemic
Panovska-Griffiths, J., Ross, J., Elkhodair, S., Baxter-Derrington, C., Laing, C., Raine, R.
10.1101/2021.01.20.21250150 — Posted: 2021-01-20
GRP78 binds SARS-CoV-2 Spike protein and ACE2 and GRP78 depleting antibody blocks viral entry and infection in vitro
Carlos, A. J., Ha, D. P., Yeh, D.-W., Van Krieken, R., Gill, P., Machida, K., Lee, A.
10.1101/2021.01.20.427368 — Posted: 2021-01-20 Discussion: Offsite
Use Of Canine Olfactory Detection For COVID-19 Testing Study On U.A.E. Trained Detection Dog Sensitivity
Granjean, D., Al Marzooqi, D. H., Lecoq-Julien, C., Al Hammadi, H. K., Alvergnat, G., Al Blooshi, K. M., Al Mazrooei, S. K., Alhmoudi, M. S., Al Ahbabi, F. M., Mohammed, Y. S., Al Falasi, N. M., Almheiri, N. M., Al Blooshi, S. M., Muzzin, Q., Desquilbet, L.
10.1101/2021.01.20.427105 — Posted: 2021-01-20
Evaluation of the effects of SARS-CoV-2 genetic mutations on diagnostic RT-PCR assays
Nakabayashi, T., Kawasaki, Y., Murashima, K., Omi, K., Yuhara, S.
10.1101/2021.01.19.426622 — Posted: 2021-01-20
Increased elastase sensitivity and decreased intramolecular interactions in the more transmissible SARS-CoV-2 variants' spike protein
Kraemer, B. R., Mochly-Rosen, D., Pokhrel, S., Lee, L., Samardzic, K.
10.1101/2021.01.19.427355 — Posted: 2021-01-20 Discussion: Onsite
A Universal Bacteriophage T4 Nanoparticle Platform to Design Multiplex SARS-CoV-2 Vaccine Candidates by CRISPR Engineering
Rao, V. B., Zhu, J., Ananthaswamy, N., Jain, S., Batra, H., Tang, W.-C., Lewry, D. A., Richards, M. L., David, S. A., Kilgore, P. B., Sha, J., Drelich, A., Tseng, C.-T., Chopra, A. K.
10.1101/2021.01.19.427310 — Posted: 2021-01-20
Neutralizing and protective human monoclonal antibodies recognizing the N-terminaldomain of the SARS-CoV-2 spike protein
Suryadevara, N., Shrihari, S., Gilchuk, P., VanBlargan, L., Binshtein, E., Zost, S., Nargi, R., Sutton, R., Winkler, E. S., Chen, E. C., Fouch, M. E., Davidson, E., Doranz, B., Carnahan, R. H., Thackray, L., Diamond, M. D., Crowe, J. E.
10.1101/2021.01.19.427324 — Posted: 2021-01-20
Estimating dates of origin and end of COVID-19 epidemics
Beneteau, T., Elie, B., Sofonea, M. T., Alizon, S.
10.1101/2021.01.19.21250080 — Posted: 2021-01-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).